Literature DB >> 27911104

Upregulation of T-cell Immunoglobulin and Mucin-Domain Containing-3 (Tim-3) in Monocytes/Macrophages Associates with Gastric Cancer Progression.

Zhenxin Wang1,2, Ni Yin2, Zixiang Zhang3, Yi Zhang3, Guangbo Zhang4, Weichang Chen1,4.   

Abstract

T-cell immunoglobulin and mucin-domain containing-3 (Tim-3) is an important immune regulatory molecule in cancer immune system. However, expression and function of Tim-3 in monocytes/macrophages in cancer progression mainly remain unclear. In this study, we analyzed Tim-3 levels in peripheral blood mononuclear cells (PBMCs) from 62 gastric cancer patients and 45 healthy controls using flow cytometry and then associated Tim-3 levels with clinical pathological data from patients. We found Tim-3 level was significantly upregulated in monocytes from gastric cancer patients compared with those from healthy controls, and that upregulated Tim-3 levels associated with depth of tumor invasion and tumor lymph node metastasis and advanced clinical stages of gastric cancer patients. Furthermore, tumor-bearing mouse experiments revealed that Tim-3 level on monocytes/macrophages associated with xenograft formation and growth. In addition, culture of monocytes from healthy controls with gastric cancer cell-conditioned medium upregulated Tim-3 expression, but IL-10, TNF-α, IFN-γ, or GM-CSF treatment or T-bet, Eomes, and T-bet/Eomes double gene knockout did not affect Tim-3 levels in blood monocytes/macrophages from human or mouse, respectively. Gal-9/Tim-3 signal was able to significantly stimulate monocyte to secrete IL-6, IL-8, and IL-10, but not IL-1β, IL-12p70, or TNF-α in presence of LPS. In conclusion, our study demonstrated that Tim-3 expressed by monocyte/macrophages might be an important mechanism in gastric cancer progression.

Entities:  

Keywords:  Gastric cancer; Tim-3; monocyte/macrophage; tumor progression

Mesh:

Substances:

Year:  2016        PMID: 27911104     DOI: 10.1080/08820139.2016.1229790

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  18 in total

1.  Molecular and clinical characterization of TIM-3 in glioma through 1,024 samples.

Authors:  Guanzhang Li; Zheng Wang; Chuanbao Zhang; Xing Liu; Jinquan Cai; Zhiliang Wang; Huimin Hu; Fan Wu; Zhaoshi Bao; Yanwei Liu; Liang Zhao; Tingyu Liang; Fan Yang; Ruoyu Huang; Wei Zhang; Tao Jiang
Journal:  Oncoimmunology       Date:  2017-07-28       Impact factor: 8.110

Review 2.  Signaling pathways and therapeutic interventions in gastric cancer.

Authors:  Zi-Ning Lei; Qiu-Xu Teng; Qin Tian; Wei Chen; Yuhao Xie; Kaiming Wu; Qianlin Zeng; Leli Zeng; Yihang Pan; Zhe-Sheng Chen; Yulong He
Journal:  Signal Transduct Target Ther       Date:  2022-10-08

3.  Generation of αGal-enhanced bifunctional tumor vaccine.

Authors:  Jian He; Yu Huo; Zhikun Zhang; Yiqun Luo; Xiuli Liu; Qiaoying Chen; Pan Wu; Wei Shi; Tao Wu; Chao Tang; Huixue Wang; Lan Li; Xiyu Liu; Yong Huang; Yongxiang Zhao; Lu Gan; Bing Wang; Liping Zhong
Journal:  Acta Pharm Sin B       Date:  2022-03-09       Impact factor: 14.903

4.  Pan-Cancer Single-Cell Analysis Reveals the Core Factors and Pathway in Specific Cancer Stem Cells of Upper Gastrointestinal Cancer.

Authors:  Leijie Li; Yujia Zhang; Yongyong Ren; Zhiwei Cheng; Yuening Zhang; Xinbo Wang; Hongyu Zhao; Hui Lu
Journal:  Front Bioeng Biotechnol       Date:  2022-05-13

Review 5.  The immune microenvironment in gastric adenocarcinoma.

Authors:  Yana Zavros; Juanita L Merchant
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-03-14       Impact factor: 73.082

6.  An Immunity-Associated lncRNA Signature for Predicting Prognosis in Gastric Adenocarcinoma.

Authors:  Xiaowen Zhao; Pingfan Wu; Dongling Liu; Changtian Li; Ling Xue; Zhe Liu; Meng Zhu; Jie Yang; Ziyi Chen; Yaling Li; Yali She
Journal:  J Healthc Eng       Date:  2022-04-25       Impact factor: 3.822

7.  Low TIM3 expression indicates poor prognosis of metastatic prostate cancer and acts as an independent predictor of castration resistant status.

Authors:  Junlong Wu; Guowen Lin; Yao Zhu; Hailiang Zhang; Guohai Shi; Yijun Shen; Yiping Zhu; Bo Dai; Dingwei Ye
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

8.  Tumor-associated macrophages (TAMs) as biomarkers for gastric cancer: A review.

Authors:  Meri R Räihä; Pauli A Puolakkainen
Journal:  Chronic Dis Transl Med       Date:  2018-09-03

9.  HAVCR1 expression might be a novel prognostic factor for gastric cancer.

Authors:  Lingling Liu; Zhaoquan Song; Yingchun Zhao; Chao Li; Hua Wei; Ji Ma; Yaowu Du
Journal:  PLoS One       Date:  2018-11-02       Impact factor: 3.240

Review 10.  Detection of Immune Checkpoint Receptors - A Current Challenge in Clinical Flow Cytometry.

Authors:  Benjamin Shibru; Katharina Fey; Stephan Fricke; André-René Blaudszun; Friederike Fürst; Max Weise; Sabine Seiffert; Maria Katharina Weyh; Ulrike Köhl; Ulrich Sack; Andreas Boldt
Journal:  Front Immunol       Date:  2021-07-01       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.